Recent advances in understanding Nrf2 agonism and its potential clinical application to metabolic and inflammatory diseases

MJ Kim, JH Jeon - International Journal of Molecular Sciences, 2022 - mdpi.com
Oxidative stress is a major component of cell damage and cell fat, and as such, it occupies a
central position in the pathogenesis of metabolic disease. Nuclear factor-erythroid-derived 2 …

CD19 chimeric antigen receptor t cell treatment: unraveling the role of B cells in systemic lupus erythematosus

J Taubmann, F Müller, M Yalcin Mutlu… - Arthritis & …, 2024 - Wiley Online Library
B cell generation of autoantibodies is a crucial step in the pathogenesis of systemic lupus
erythematosus (SLE). After their differentiation in the bone marrow, B cells populate the …

Age-associated B cells are heterogeneous and dynamic drivers of autoimmunity in mice

KM Nickerson, S Smita, KB Hoehn… - Journal of Experimental …, 2023 - rupress.org
Age-associated B cells (ABCs) are formed under inflammatory conditions and are
considered a type of memory B cell (MBC) expressing the transcription factor T-bet. In SLE …

Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches

A Merino‐Vico, G Frazzei… - European journal of …, 2023 - Wiley Online Library
Autoimmune diseases are characterized by the recognition of self‐antigens by the immune
system, which leads to inflammation and tissue damage. B cells are directly and indirectly …

ATR-mediated DNA damage responses underlie aberrant B cell activity in systemic lupus erythematosus

T Manolakou, D Nikolopoulos, D Gkikas, A Filia… - Science …, 2022 - science.org
B cells orchestrate autoimmune responses in patients with systemic lupus erythematosus
(SLE), but broad-based B cell–directed therapies show only modest efficacy while blunting …

TLR7 signaling in lupus B cells: new insights into synergizing factors and downstream signals

AB Satterthwaite - Current rheumatology reports, 2021 - Springer
Abstract Purpose of the Review Systemic lupus erythematosus (SLE) is driven by nucleic
acid-containing antigens that stimulate endosomal TLRs. We review new advances in our …

Identification of biomarkers to stratify response to B-cell-targeted therapies in systemic lupus erythematosus: an exploratory analysis of a randomised controlled trial

M Shipa, LR Santos, DX Nguyen… - The Lancet …, 2023 - thelancet.com
Background Systemic lupus erythematosus (SLE) is a complex autoimmune disease
associated with widespread immune dysregulation and diverse clinical features. Immune …

ω-3 polyunsaturated fatty acid alleviates systemic lupus erythematosus by suppressing autoimmunity in a murine model

A Liu, Z Li, J Zeng, Y Peng, S Wang, X Bi, Z Zhao… - International …, 2024 - Elsevier
Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune inflammatory disease
that damages multiple organs by the production of autoantibodies. Numerous research …

[HTML][HTML] Белимумаб в лечении системной красной волчанки: 20 лет фундаментальных исследований, 10 лет клинической практики

ЕЛ Насонов, ТВ Попкова, АМ Лила - Научно-практическая …, 2021 - cyberleninka.ru
В настоящее время получены веские доказательства фундаментальной роли
патологической активации В-клеток в патогенезе иммуновоспалительных …

[HTML][HTML] Системная красная волчанка: история и современность

ЕЛ Насонов, СК Соловьев… - Научно-практическая …, 2022 - cyberleninka.ru
Системная красная волчанка (СКВ)-системное аутоиммунное ревматическое
заболевание неизвестной этиологии, характеризующееся гиперпродукцией …